Marking shifts in human research ethics in the development of biobanking

Public Health Ethics

Volumn 8, Issue 1, 2015, Pages 63-71

  Chalmers, Don ^a   Burgess, Michael ^b   Edwards, Kelly ^c   Kaye, Jane ^d   Meslin, Eric M ^e   Nicol, Dianne ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Indiana University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOBANK; DATA BASE; HEALTH CARE SYSTEM; HUMAN; HUMAN RIGHTS ABUSE; MEDICAL RESEARCH; PARTICIPATORY MANAGEMENT; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RESEARCH ETHICS; RESEARCH SUBJECT; SOCIAL WELFARE; TRUST;

EID: 84926672688     PISSN: 17549973     EISSN: 17549981     Source Type: Journal    
DOI: 10.1093/phe/phu023     Document Type: Article

References (75)

1. American College of Medical Genetics and Genomics. (2014). Incidental Findings in Clinical Genomics: A Clarification. American College of Medical Genetics and Genomics, available from: https:// www. acmg. net/docs/Incidental-Findings-in-Clinical- Genomics-A-Clarication. pdf [accessed 30 July 2014].
2. Australian Government National Health and Medical Research Council. (2010). Biobanks Information Paper. Australian Government, available from: http://www. nhmrc. gov. au/-files-nhmrc/file/your- health/egenetics/practioners/biobanks-information- paper. pdf [accessed 24 July 2014].
3. Benatar, S. (2002). Reflections and Recommendations on Research Ethics in Developing Countries. Social Science and Medicine, 54, 1131-1141; 1132.
4. Beskow, L. M., Friedman, J. Y., Hardy, N. C., Lin, L. and Weinfurt, K. P. (2010). Developing a Simplified Consent Form for Biobanking. PLoS One, 5, e13302.
5. Bovenberg, J. (2005). Towards an International System of Ethics and Governance of Biobanks: A "Special Status" for Genetic Data? Critical Public Health, 15, 369-383.
6. Burgess, M. M. (2007). Proposing Modesty for Informed Consent. Social Science and Medicine, 65, 2284-2295.
7. Burgess, M. M. (2014). From 'trust us' to Participatory Governance: Deliberative Publics and Science Policy. Public Understanding of Science, 23, 48-52.
8. Campbell, A. V. (2007). The Ethical Challenges of Genetic Databases: Safeguarding Altruism and Trust. King's Law Journal, 18, 237-245.
9. Cambon-Thomsen, A., Ducoumau, P., Gourraud, P. A. and Pontille, D. (2003). Biobanks for Genomics and Genomics for Biobanks. Comparative and Functional Genomics, 4, 628-634.
10. Capps, B. (2012). The Public Interest, Public Goods, and Third-Party Access to UK Biobank. Public Health Ethics, 5, 240-251.
11. Caulfield, T., McGuire, A. L., Cho, M., Buchanan, J. A., Burgess, M. M., Danilczyk, D., Diaz, C. M., Felsenfeld, A. L., Fryer-Edwards, K., Green, S. K., Hodosh, M. A., Juengst, E. T., Kaye, J., Kedes, L., Knoppers, B. M., Lemmens, T., Meslin, E., Murphy, J., Nussbaum, R. L., Otlowski, M., Pullman, D., Ray, P. L., Sugarman, J. and Timmons, M. (2008). Research Ethics Recommendations for Whole-Genome Research: Consensus Statement. PLoS Biology, 6, 430-435.
12. Caulfield, T. (2007). Biobanks and Blanket Consent: The Proper Place of the Public Good and Public Perception Rationales. King's Law Journal, 18, 209-226.
13. Chalmers, D. (2004). Research Involving Humans: A Time for Change? The Journal of Law, Medicine and Ethics, 4, 583-495.
14. Chalmers, D. and Nicol, D. (2008). Human Genetic Research Databases and Biobanks. Journal of Law and Medicine, 15, 538-554.
15. Chalmers, D. and Nicol, D. (2004). Commercialisation of Biotechnology: Public Trust and Research. International Journal of Biotechnology, 6, 116-133.
16. Chalmers, D., Nicol, D., Nicolas, P. and Zeps, N. (2014). A Role for Research Ethics Committees in Exchanges of Biospecimens Through Material Transfer Agreements. Journal of Bioethical Inquiry, 11, 301-306.
17. Clayton, E. W., Smith, M., Fullerton, S. M., Burke, W., McCarty, C. A., Koenig, B. A., McGuire, A. L., Beskow, L. M., Dressler, L., Lemke, A. A., Ramos, E. M. and Rodriguez, L. L. (2010). Confronting Real Time Ethical, Legal, and Social Issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genetics in Medicine, 12, 616-620.
18. Dawson, J. and Peart, N. (2003). The Law of Research: A Guide. Dunedin: University of Otago Press, pp. 47-60.
19. Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., Wareham, N., Ahmed, S., Healey, C. S. and Bowman, R. (2007). Genome-wide Association Study Identifies Novel Breast Cancer Susceptibility Loci. Nature, 447, 1087-1093.
20. Evans, B. J. and Meslin, E. M. (2006). Encouraging Translational Research Through Harmonization of FDA and Common-rule Informed Consent Requirements for Research with Banked Specimens. Journal of Legal Medicine, 27, 119-166.
21. Fullerton, S. M., Anderson, N. R., Guzauskas, G., Freeman, D. and Fryer-Edwards, K. (2010). Meeting the Governance Challenges of Next Generation Biorepository Research. Science Translational Medicine, 2, 15cm3.
22. Gottweis, H. and Petersen, A. (eds) (2008). Biobanks-Governance in Comparative Perspective. New York: Routledge.
23. Grady, C. (2005). The Challenge of Assuring Continued Post-trial Access to Beneficial Treatment. Yale Journal of Health Policy, Law, and Ethics, 1, 425-435.
24. Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A., Nussbaum, R. L., O'Daniel, J. M., Ormond, K. E., Rehm, H. L., Watson, M. S., Williams, M. S. and Biesecker, L. G. (2013). Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. American College of Medical Genetics and Genomics, available from: http://www. genome. gov/Pages/Health/HealthCareProvidersInfo/ACMG- Incidental-Findings-Report. pdf [accessed 30 July 2014].
25. Hansson, M., Dillner, J., Bartram, C., Carlson, J. and Helgesson, G. (2006). Should Donors be Allowed to Give Broad Confsent to Future Biobank Research? The Lancet Oncology, 7, 266-269.
26. Hardy, B., Seguin, B., Goodsaid, F., Jimenez-Sanchez, G., Singer, P. A. and Daar, A. S. (2008). The Next Steps for Genomic Medicine: Challenges and Opportunities for the Developing World. Nature Reviews Genetics, 9, S23-S27.
27. Henderson, G. E., Cadigan, R. J., Edwards, T. P., Conlon, I., Nelson, A. G., Evans, J. P., Davis, A. M., Zimmer, C. and Weiner, B. J. (2013). Characterizing Biobank Organizations in the U. S.: Results From a National Survey. Genome Medicine, 5, 3.
28. Homer, N., Szelinger, S., Redman, M., Duggan, D., Tembe, W., Muehling, J., Pearson, J. V., Stephan, D. A., Nelson, S. F. and Craig, D. W. (2008). Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays. Plos Genetics, 4, 1-9.
29. Hudson, T. (2010). International Network of Cancer Genome Projects. Nature, 464, 993-998.
30. Im, H. K., Gamazon, E., Nicolae, D. and Cox, N. (2012). On Sharing Quantitative Trait GWAS Results in an era of Multiple-omics and the Limits of Genomic Privacy. American Journal of Human Genetics, 90, 591-598.
31. ISBER. (2008). Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. Cell Preservation Technology, 6, 1-58.
32. Kaye, J. (2011). From Single Biobanks to International Networks: Developing e-governance. Human Genetics, 130, 377-382.
33. Kaye, J. (2007). Governing Genetic Databases: Collection, Storage and Use. King's Law Journal, 18, 201-208.
34. Kaye, J., Curren, L., Anderson, N., Edwards, K., Fullerton, S. M., Kanellopoulou, N., Lund, D., MacArthur, D. G., Mascalzoni, D., Shepherd, J., Taylor, P. L., Terry, S. F. and Winter, S. F. (2012a). Science and Society: From Patients to Partners: Participant-centric Initiatives in Biomedical Research. Nature Reviews Genetics, 13, 371-376.
35. Kaye, J., Meslin, E., Knoppers, B., Juengst, E., Deschenes, M., Cambon-Thomsen, A., Chalmers, D., De Vries, J., Edwards, K. and Hoppe, N. (2012b). 'ELSI 2. 0: A New Collaboratory for Genomics and Society Research. Science, 336, 673-674.
36. Kaye, J. and Stranger, M. (2009). Principles and Practice in Biobank Governance. Surrey: Ashgate.
37. Kaye, J., Whitley, E. A., Lund, D., Morrison, M., Teare, H. and Melham, K. (2015). Dynamic Consent: A Patient Interface for Twenty-first Century Research Networks. European Journal of Human Genetics, 23, 141-146.
38. Knoppers, B. M. (ed. ) (2007). Genomics and Public Health. Leiden: Martinus Nijhoff.
39. Knoppers, B. M. and Chadwick, R. (2006). Human Genetic Research: Emerging Trends in Ethics. Nature Reviews Genetics, 6, 75-79.
40. Knoppers, B. M. and Sheremeta, L. (2003). Beyond the Rhetoric: Population Genetics and Benefit-sharing. Health Law Journal, 11, 89-117.
41. Kristin, S., Bjørn Kåre, M. and Berge, S. (2013). Broad Consent Versus Dynamic Consent in Biobank Research: Is Passive Participation an Ethical Problem? European Journal of Human Genetics, 21, 897-902.
42. Laurie, G. (2008). Consent for Biobanking: Lack of Dissent When Opting-in Does Not Necessarily Support 'opt-out'. British Medical Journal, 337, 186-187.
43. Llewellyn, J., Downie, J. and Holmes, R. (2003). Protecting Health Research Subjects: A Jurisdictional Analysis. Health Law Journal, pp. 207-242.
44. McGuire, A. L., Basford, M., Dressler, L. G., Fullerton, S. M., Koenig, B. A., Li, R., McCarty, C. A., Ramos, E., Smith, M. E., Somkin, C. P., Waudby, C., Wolf, W. A. and Clayton, E. W. (2010). Ethical and Practical Challenges of Sharing Data from Genome-wide Association Studies: The eMERGE Consortium Experience. Genome Research, 21, 1001-1007.
45. Mascalzoni, D., Hicks, A., Pramstaller, P. and Wjst, M. (2008). Informed Consent in the Genomics era. PLoS Medecine, 5, e192.
46. McLean, S. (2004). Regulating Research and Experimentation: A View from the UK. Journal of Law Medicine and Ethics, 32, 604-612.
47. Minkler, M. and Wallerstein, N. (eds) (2008). Community-based Participatory Research for Health: from Process to Outcomes. 2nd edn. San Francisco: Jossey-Bass.
48. Moreno, J., Caplan, A. L. and Wolpe, P. R. (1998). Updating Protections for Human Subjects Involved in Research. JAMA, 280, 1951-1958.
49. National Institutes of Health Revitalization Act. (1993). Available from: http://orwh. od. nih. gov/about /pdf/NIH-Revitalization-Act-1993. pdf [accessed 2 September 2014].
50. NBAC, National Bioethics Advisory Commission. (2001). Chapter 4 Assessing Risks and Potential Benefits and Evaluating Vulnerability. Report Ethical and Policy issues in Research involving Human Participants, Vol. 1. Maryland: Bethesda.
51. National Cancer Institute. (2013). Cancer Genome Atlas. U. S. Department of Health and Human Services, available from: http://cancergenome. nih. gov/ [accessed 30 July 2014].
52. National Cancer Institute. (2011). Best Practices for Biospecimen Resources. National Institutes of Health, available from: http://biospecimens. cancer. gov/bestpractices/2011-NCIBestPractices. pdf [accessed 30 July 2014].
53. National Institutes of Health. (2004). Iceland's Research Resources: The Health Sector Database, Genealogy databases and Biobanks, available from: http://grants. nih. gov/grants/icelandic-research. pdf [accessed 30 July 2014].
54. Nicol, D. (2006). Public Trust, Intellectual Property and Human Genetic Databases; the Need to Address Benefit Sharing. Journal of International Biotechnology Law, 3, 89-103.
55. Nicol, D. and Gold, E. R. (2012). Standards for biobank access and intellectual property. In Rimmer, M. and McLennan, A. (eds), Intellectual Property and Emerging Technologies: The New Biology. Cheltenham UK: Queen Mary Studies in Intellectual Property, Edward Elgar, pp. 133-157.
56. OECD. (2009). OECD Guidelines for Human Biobanks and Genetic Research Databases, available from: http://www. oecd. org/dataoecd/41/47/44054609. pdf [accessed 30 July 2014].
57. O'Doherty, K., Burgess, M. M., Edwards, K., Gallagher, R., Hawkins, A., Kaye, J., McCaffrey, V. and Winickoff, D. (2011). From Consent to Institutions: Adaptive Governance for Genomic Biobanks. Social Science and Medicine, 73, 367-374.
58. Ohm, P. (2010). Broken Promises of Privacy: Responding to the Surprising Failure of Anonymization. UCLA Law Review, 57, 1701-1777.
59. Public Population Project in Genomics and Society. (2005). Ethics Governance and Public Engagement, available from: http://www. p3gobservatory. org/re pository/ethics. htm [accessed 20 July 2014].
60. Schadt, E., Woo, S. and Hao, K. (2012). Baysian Method to Predict Individual SNP Genotypes from Gene Expression Data. Nature Genetics, 44, 603-608.
61. Shapiro, H. T. and Meslin, E. M. (2001). Ethical Issues in the Design and Conduct of Clinical Trials in Developing Countries. New England Journal of Medicine, 345, 139-141.
62. Sheehan, M. (2011). Can Broad Consent Be Informed Consent? Public Health Ethics, 4, 226-235.
63. Stein, D. T. and Terry, S. F. (2013). Reforming Biobank Consent Policy: A Necessary Move Away from Broad Consent Toward Dynamic Consent. Genetic Testing and Molecular Biomarkers, 17, 855-856.
64. Sugarman, J., Mastroianni, A. C. and Kahn, J. P. (eds) (1998). Beyond Consent: Seeking Justice in Research. New York: Oxford University Press.
65. Steiner, J. (2012). The Foundations of Deliberative Democracy. Cambridge: Cambridge University Press.
66. Susan G Komen for the Cure. (2011). Tissue Bank at the IU Simon Cancer Center, available from: https://ko mentissuebank. iu. edu/ [accessed 30 July 2014].
67. Taylor, P. (2008). Personal Genomes: When Consent Gets in the Way. Nature, 456, 32-33.
68. UK Biobank. (2007). Ethical and Governance Framework, available from: http://www. ukbiobank. ac. uk/wp-content/uploads/2011/05/EGF20082. pdf [accessed 24 July 2014].
69. UNESCO. (2005). Universal Declaration on Bioethics and Human Rights, available from: http://portal. unesco. org/en/ev. php-URL-ID=31058&URL-DO= DO-TOPIC&URL-SECTION=201. html [accessed 30 July 2014].
70. US Department of Health and Human Services. (2011). Advance Notice of Proposed Rulemaking for Revisions to the Common Rule, available from: http://www. hhs. gov/ohrp/humansubjects/anprm2011page. html [accessed 30 July 2014].
71. Vanderbilt University Medical Center. (2012). Vanderbilt DNA Databank, available from: https://medschool. vanderbilt. edu/dbmi/biovu-vanderbilts-dna-databank [accessed 30 July 2014].
72. Winickoff, D. E. (2007). Partnership in U. K. Biobank: A Third Way for Genomic Property? Journal of Law, Medicine and Ethics, 35, 440-456.
73. Wolf, S. M., Crock, B. N., Van Ness, B., Lawrence, F., Kahn, J. P., Beskow, L. M., Cho, M. K., Christman, M. F., Green, R. C., Hall, R., Illes, J., Keane, M., Knoppers, B. M., Koenig, B. A., Kohane, I. S., LeRoy, B., Maschke, K. J., McGeveran, W., Ossorio, P., Parker, L. S., Petersen, G. M., Richardson, H. S., Scott, J. A., Terry, S. F., Wilfond, B. S. and Wolf, W. A. (2012). Managing Incidental Findings and Research Results in Genomic Research Involving Biobanks and Archived Data Sets. Genetics in Medicine, 14, 361-384.
74. Yuille, M., van Ommen, G. J., Brechot, C., Cambon-Thomsen, A., Dagher, G., Landegren, U., Litton, J. E., Pasterk, M., Taussig, M., Wichmann, H. E. and Zatloukal, K. (2008). Biobanking for Europe. Briefings in Bioinformatics, 9, 14-24.
75. Zong, Z. (2008). Should Post-trial Provision of Beneficial Experimental Interventions be Mandatory in Developing Countries?' Journal of Medical Ethics, 34, 188-192.